Skip to main content

ADVERTISEMENT

Nader Tavakoli, MD, CMD, FAAFP

Feature
08/17/2017
Nader Tavakoli, MD, CMD, FAAFP
Sidrah Khan, MD
Shelby Knowles, MD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
...
08/17/2017
Journal of Clinical Pathways
Feature
06/14/2017
Nader Tavakoli, MD, CMD, FAAFP
Christopher Riley, MD
Emily Chan, MD
Paul Newman, MD, MBA, MS
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD
Abstract: Although clinical pathways are most often developed for very narrow diagnoses with limited pharmaceutical treatments, they are even more needed to provide direction for symptom management involving multiple...
Abstract: Although clinical pathways are most often developed for very narrow diagnoses with limited pharmaceutical treatments, they are even more needed to provide direction for symptom management involving multiple...
...
06/14/2017
Journal of Clinical Pathways